4.8400
-0.0100
(-0.21%)
At close: April 17 at 4:00:01 PM EDT
4.9796
+0.14
+(2.88%)
After hours: April 17 at 5:31:23 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-56,015
-56,015
-37,009
-43,483
-65,665
Investing Cash Flow
-39,240
-39,240
208
-23,964
66,062
Financing Cash Flow
104,139
104,139
37,057
43,173
24,861
End Cash Position
23,695
23,695
14,811
14,555
38,829
Income Tax Paid Supplemental Data
7
7
14
--
--
Interest Paid Supplemental Data
2,670
2,670
--
--
--
Capital Expenditure
-2,446
-2,446
-331
-130
-4,151
Issuance of Capital Stock
85,628
85,628
37,389
69,428
24,030
Issuance of Debt
20,000
20,000
--
--
--
Repurchase of Capital Stock
--
--
--
-26,250
--
Free Cash Flow
-58,461
-58,461
-37,340
-43,613
-69,816
12/31/2021 - 9/19/1980
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALDX Aldeyra Therapeutics, Inc.
2.1900
+8.96%
MIST Milestone Pharmaceuticals Inc.
0.8889
+8.80%
ATRA Atara Biotherapeutics, Inc.
6.17
+5.65%
RARE Ultragenyx Pharmaceutical Inc.
35.69
+2.03%
SPRB Spruce Biosciences, Inc.
0.1187
-3.50%
URGN UroGen Pharma Ltd.
9.67
-6.93%
NUVB Nuvation Bio Inc.
1.9700
+4.79%
KALV KalVista Pharmaceuticals, Inc.
12.00
+2.17%
UNCY Unicycive Therapeutics, Inc.
0.6003
+0.38%
TLX Telix Pharmaceuticals Limited
16.71
+1.03%